| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $148.5M | +33.8% |
| Cost of Revenue | $47.9M | +8.4% |
| R&D Expense | $56.1M | +28.2% |
| SG&A Expense | $45.3M | +20.4% |
| Pre-tax Income | $470K | +102.6% |
| Income Tax | $3.9M | +23.0% |
| Net Income | -$3.4M | +84.0% |
| EPS (Basic) | -$0.09 | +84.5% |
| EPS (Diluted) | -$0.09 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $119.6M | +332.1% |
| Short-term Investments | $19.6M | -82.6% |
| Accounts Receivable | $42.2M | +5.2% |
| Current Assets | $193.4M | +2.6% |
| Total Assets | $278.7M | +1.8% |
| Current Liabilities | $58.2M | +32.8% |
| Total Liabilities | $68.7M | +26.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $32.3M | +661.2% |
| Capital Expenditures | $8.4M | +129.0% |
| Investing Cash Flow | $84.6M | +1912.7% |
| Financing Cash Flow | -$24.3M | -339.9% |
| Free Cash Flow | $23.9M | +4083.7% |
| +84.5% |
| Stockholders' Equity |
| $210.0M |
| -4.4% |